A recent multicentre retrospective cohort study of patients with HNF1β mutations showed that stage 3–4 chronic kidney disease was present in 44% of cases, and end-stage renal disease in 21% of cases [35]. The gene discussed is HNF1B; the disease is stage 5 chronic kidney disease.